LENTIVIRUS
Streamline lentivirus production with dbDNA™
dbDNA™ is premium-quality, cell-free DNA template that offers a stream-lined alternative to plasmid DNA in lentivirus production. By reducing DNA contamination while preserving high infectious titres, dbDNA™ supports more consistent, efficient therapeutic applications.
OVERVIEW
Enhancing your lentiviral vector development with high-purity, scalable DNA solutions
30% less DNA
Achieves equivalent titre with a 30% reduction in DNA input with dbDNA™
Rapid manufacture
dbDNA™ facilitates rapid manufacturing and delivers high-purity results
>70% reduction in non-functional virus
Non-functional lentivirus is reduced by >70% with dbDNA™
Benefits of Lentivirus in your workflow
dbDNA™ eliminates common production challenges, delivering optimised lentiviral vectors with superior efficiency and purity.
Higher infectious titres with lower DNA input.
Eliminates bacterial sequences for enhanced purity.
Streamlined production for rapid research timelines.
Scalable synthesis for clinical-grade applications.
GMP-compliant material
Optimised vector performance for gene therapies.
Explore off-the-shelf catalogue products
Get started quickly with ready-made constructs for lentivirus applications.
VSV-G
eGFP transgene
GagPol
Touchlight vs competitors
Our technology eliminates bacterial contamination risks, improves efficiency, and enables scalable production compared to conventional fermentation-based approaches.
RESOURCES
Learn more about dbDNA™ and its role in lentivirus development
Reap the benefits of our latest research and insights into enzymatic DNA innovation, and discover how it can enhance your lentiviral vector production for advanced therapies.
